Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Ruud Dings

Concepts (319)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Angiogenesis Inhibitors
25
2022
186
3.770
Why?
Proteins
17
2010
351
2.270
Why?
Neovascularization, Pathologic
17
2022
158
2.240
Why?
Calixarenes
7
2017
9
1.800
Why?
Melanoma, Experimental
6
2021
34
1.720
Why?
Galectin 1
8
2024
19
1.690
Why?
Antineoplastic Agents
14
2024
1232
1.450
Why?
Peptides
20
2017
234
1.260
Why?
Mice
48
2026
5982
1.210
Why?
Neoplasms
14
2024
1334
1.110
Why?
Animals
54
2026
13526
0.990
Why?
Endothelial Cells
10
2022
289
0.950
Why?
Lung Neoplasms
5
2024
645
0.950
Why?
Gold
7
2023
81
0.840
Why?
Ovarian Neoplasms
8
2008
459
0.820
Why?
Oxygen
6
2020
338
0.790
Why?
Cell Line, Tumor
19
2026
1470
0.790
Why?
Carcinoma, Non-Small-Cell Lung
1
2024
175
0.710
Why?
Carcinoma, Squamous Cell
4
2019
332
0.700
Why?
Proto-Oncogene Proteins c-met
1
2021
23
0.670
Why?
Peptide Fragments
5
2013
209
0.670
Why?
Mammary Neoplasms, Experimental
6
2015
122
0.660
Why?
Radiation-Sensitizing Agents
4
2023
50
0.650
Why?
Head and Neck Neoplasms
3
2019
291
0.640
Why?
Carcinoma, Lewis Lung
1
2019
10
0.620
Why?
Molecular Targeted Therapy
2
2018
138
0.600
Why?
Preservation, Biological
1
2018
9
0.590
Why?
Lymphocytes, Tumor-Infiltrating
1
2019
89
0.580
Why?
Radiation Tolerance
5
2020
78
0.580
Why?
Protein Kinase Inhibitors
1
2021
233
0.580
Why?
CD8-Positive T-Lymphocytes
1
2019
145
0.570
Why?
Anti-Bacterial Agents
4
2019
830
0.560
Why?
Galectins
1
2018
7
0.560
Why?
Metal Nanoparticles
4
2023
67
0.530
Why?
Hyperthermia, Induced
3
2019
114
0.520
Why?
Mice, Nude
12
2019
232
0.510
Why?
Bacteria
1
2018
226
0.510
Why?
Radiotherapy
5
2021
126
0.500
Why?
Xenograft Model Antitumor Assays
11
2020
228
0.480
Why?
Pseudomonas aeruginosa
2
2013
78
0.450
Why?
Nanoparticles
3
2026
133
0.430
Why?
Combined Modality Therapy
11
2020
640
0.400
Why?
Benzofurans
2
2012
19
0.400
Why?
Cytotoxins
1
2013
15
0.390
Why?
Cell Proliferation
10
2024
1031
0.390
Why?
Drug Design
4
2014
121
0.380
Why?
Humans
45
2026
53230
0.380
Why?
Pseudomonas Infections
1
2013
54
0.380
Why?
Oxidation-Reduction
3
2024
333
0.380
Why?
Endothelium, Vascular
8
2010
262
0.370
Why?
Carbohydrate Metabolism
1
2012
25
0.370
Why?
Nanostructures
3
2023
41
0.370
Why?
Neoplasms, Experimental
4
2020
112
0.360
Why?
Benzeneacetamides
2
2024
12
0.360
Why?
Glutaminase
2
2024
18
0.360
Why?
Bacteremia
1
2013
87
0.360
Why?
Sesquiterpenes
3
2010
90
0.350
Why?
Angiostatic Proteins
1
2011
1
0.340
Why?
Immunity, Cellular
1
2011
64
0.330
Why?
Cell Survival
8
2024
600
0.330
Why?
Molecular Mimicry
2
2007
35
0.330
Why?
Dendritic Cells
3
2021
133
0.320
Why?
Endothelium
4
2022
38
0.320
Why?
Carboplatin
3
2024
57
0.310
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2008
1043
0.310
Why?
Tumor Necrosis Factor-alpha
4
2019
392
0.300
Why?
Immunotherapy, Adoptive
1
2011
163
0.290
Why?
Apoptosis
7
2024
1139
0.290
Why?
Cells, Cultured
8
2013
1569
0.290
Why?
Vascular Endothelial Growth Factor A
7
2022
189
0.290
Why?
Intercellular Adhesion Molecule-1
5
2022
59
0.290
Why?
T-Lymphocytes
1
2011
321
0.290
Why?
Structure-Activity Relationship
6
2012
396
0.290
Why?
Polyethylene Glycols
3
2021
95
0.280
Why?
Mice, Inbred C57BL
8
2021
1925
0.280
Why?
Phototherapy
2
2019
26
0.280
Why?
Female
25
2026
28782
0.270
Why?
Amino Acid Sequence
5
2012
563
0.270
Why?
Tumor Cells, Cultured
6
2019
441
0.270
Why?
Drug Resistance, Neoplasm
2
2024
350
0.250
Why?
Magnetic Resonance Spectroscopy
5
2012
250
0.250
Why?
Antibodies, Monoclonal
2
2007
477
0.250
Why?
Blood Vessels
4
2015
73
0.240
Why?
Molecular Sequence Data
5
2012
759
0.240
Why?
Disease Models, Animal
7
2020
1517
0.230
Why?
Exosomes
1
2026
58
0.220
Why?
Mice, Inbred BALB C
6
2026
310
0.220
Why?
Cell Division
7
2010
289
0.210
Why?
Bystander Effect
1
2024
25
0.210
Why?
Cysteine
1
2024
50
0.210
Why?
Human Umbilical Vein Endothelial Cells
3
2014
102
0.210
Why?
Buthionine Sulfoximine
1
2024
13
0.210
Why?
Nanotubes
2
2021
17
0.210
Why?
Models, Molecular
4
2024
352
0.210
Why?
Thiadiazoles
2
2024
18
0.200
Why?
Flow Cytometry
2
2017
400
0.200
Why?
Cisplatin
1
2024
282
0.180
Why?
Alanine
3
2012
43
0.180
Why?
Protein Binding
3
2012
670
0.180
Why?
Carcinoma, Renal Cell
1
2022
112
0.180
Why?
Binding Sites
2
2012
373
0.180
Why?
Optical Imaging
2
2020
27
0.170
Why?
Silver
2
2021
49
0.170
Why?
Kidney Neoplasms
1
2022
181
0.170
Why?
Polyurethanes
1
2021
10
0.170
Why?
Radiation
1
2020
14
0.170
Why?
Materials Testing
1
2021
55
0.170
Why?
Forkhead Transcription Factors
1
2021
120
0.170
Why?
Spectrum Analysis
1
2020
50
0.160
Why?
Biocompatible Materials
1
2021
67
0.160
Why?
CD4-Positive T-Lymphocytes
1
2021
166
0.160
Why?
Mice, Knockout
3
2012
910
0.160
Why?
Neoplasm Transplantation
5
2007
86
0.160
Why?
Disease Progression
3
2019
880
0.150
Why?
Oxygen Consumption
1
2020
201
0.150
Why?
Lactose
2
2024
8
0.150
Why?
Spectrum Analysis, Raman
1
2019
42
0.150
Why?
Immunotherapy
1
2020
266
0.140
Why?
Biological Assay
1
2018
46
0.140
Why?
Time Factors
6
2017
2991
0.140
Why?
Specimen Handling
1
2018
63
0.140
Why?
Drug Delivery Systems
2
2019
148
0.140
Why?
Indazoles
1
2018
47
0.140
Why?
Carbohydrates
1
2018
42
0.140
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2018
62
0.140
Why?
Temperature
1
2018
165
0.140
Why?
Feces
1
2018
159
0.140
Why?
Cell Hypoxia
4
2015
82
0.140
Why?
Histocompatibility Antigens Class II
1
2017
35
0.130
Why?
Neoplastic Cells, Circulating
1
2017
34
0.130
Why?
Tumor Microenvironment
1
2019
274
0.130
Why?
Drug Therapy, Combination
1
2018
405
0.130
Why?
Epithelial Cells
1
2018
218
0.130
Why?
Male
9
2019
27435
0.120
Why?
Cell Line
4
2017
1016
0.120
Why?
Lipopolysaccharides
2
2008
203
0.120
Why?
Umbilical Veins
4
2010
21
0.120
Why?
Enzyme Inhibitors
1
2018
371
0.120
Why?
Molecular Imaging
1
2015
28
0.120
Why?
Leukocytes
3
2006
58
0.110
Why?
Azides
1
2014
9
0.110
Why?
Tumor Burden
2
2013
132
0.110
Why?
Fluorine Radioisotopes
1
2014
25
0.110
Why?
Immunohistochemistry
5
2020
975
0.110
Why?
Cell Transformation, Neoplastic
2
2007
187
0.110
Why?
Interleukin-2
2
2021
69
0.110
Why?
Drug Synergism
2
2005
147
0.100
Why?
Cell Adhesion
3
2006
163
0.100
Why?
Piperacillin
1
2013
24
0.100
Why?
Peptidomimetics
1
2012
2
0.100
Why?
Penicillanic Acid
1
2013
21
0.100
Why?
Agglutination Tests
1
2012
5
0.090
Why?
Allosteric Regulation
1
2012
16
0.090
Why?
Inflammation Mediators
1
2013
115
0.090
Why?
Cell Cycle
1
2013
237
0.090
Why?
Antimicrobial Cationic Peptides
2
2008
28
0.090
Why?
Neoplastic Stem Cells
1
2012
90
0.090
Why?
Up-Regulation
2
2011
456
0.090
Why?
Partial Pressure
1
2011
14
0.090
Why?
Glutamine
2
2024
177
0.080
Why?
Metformin
1
2012
84
0.080
Why?
Fibroblasts
1
2013
363
0.080
Why?
Adjuvants, Immunologic
1
2011
52
0.080
Why?
Chemotherapy, Adjuvant
1
2011
122
0.080
Why?
Cell Movement
4
2006
279
0.080
Why?
Spiro Compounds
1
2010
8
0.080
Why?
Cytokines
1
2013
627
0.080
Why?
Lignans
1
2008
7
0.070
Why?
Salmonella typhimurium
1
2008
39
0.070
Why?
Klebsiella pneumoniae
1
2008
21
0.070
Why?
Amino Acid Substitution
1
2008
79
0.070
Why?
Furans
1
2008
30
0.070
Why?
Surface Properties
1
2007
61
0.070
Why?
Escherichia coli
1
2008
183
0.070
Why?
Angiostatins
2
2006
2
0.060
Why?
Endotoxins
1
2006
23
0.060
Why?
Vascular Neoplasms
1
2007
17
0.060
Why?
Concept Formation
1
2006
13
0.060
Why?
Gram-Negative Bacteria
1
2006
34
0.060
Why?
Protein Structure, Secondary
2
2003
71
0.060
Why?
Interleukin-8
1
2006
85
0.060
Why?
Genes, Synthetic
1
2005
1
0.060
Why?
Tissue Distribution
1
2026
174
0.060
Why?
Protein Engineering
1
2005
18
0.060
Why?
Antibodies, Monoclonal, Humanized
1
2007
238
0.060
Why?
Cloning, Molecular
1
2005
175
0.060
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2006
146
0.060
Why?
Angiogenic Proteins
1
2004
5
0.060
Why?
Colonic Neoplasms
1
2006
162
0.050
Why?
Histones
1
2006
318
0.050
Why?
Dietary Supplements
1
2008
479
0.050
Why?
Protein Unfolding
1
2024
7
0.050
Why?
Feasibility Studies
1
2006
411
0.050
Why?
Disulfides
1
2024
18
0.050
Why?
Diphtheria Toxin
1
2004
4
0.050
Why?
Mutagenesis, Site-Directed
1
2024
97
0.050
Why?
Protein Folding
1
2024
60
0.050
Why?
Mammary Neoplasms, Animal
1
2004
33
0.050
Why?
Osmosis
1
2003
3
0.050
Why?
Infusion Pumps
1
2003
12
0.050
Why?
Dose-Response Relationship, Drug
2
2004
1367
0.050
Why?
Circular Dichroism
1
2003
42
0.050
Why?
Plasminogen
1
2003
3
0.050
Why?
Serum Albumin
1
2003
56
0.050
Why?
Extracellular Matrix
1
2003
116
0.050
Why?
Immune Tolerance
1
2022
91
0.050
Why?
Gene Expression Regulation, Neoplastic
4
2008
868
0.050
Why?
Reactive Oxygen Species
1
2024
421
0.050
Why?
Endostatins
3
2007
4
0.050
Why?
Neoplasm Invasiveness
1
2022
281
0.040
Why?
Immune System
1
2021
41
0.040
Why?
Immunity
1
2021
35
0.040
Why?
Melanoma
1
2004
277
0.040
Why?
Ethers
1
2021
7
0.040
Why?
Regenerative Medicine
1
2021
12
0.040
Why?
Tissue Scaffolds
1
2021
40
0.040
Why?
Angiogenesis Inducing Agents
1
2000
8
0.040
Why?
Dose-Response Relationship, Radiation
1
2020
187
0.040
Why?
Adenocarcinoma
1
2004
405
0.040
Why?
Tissue Engineering
1
2021
74
0.040
Why?
Bone Marrow Cells
1
2021
188
0.040
Why?
Mice, Inbred C3H
2
2012
81
0.040
Why?
Gene Expression Profiling
1
2004
1112
0.040
Why?
Skin Neoplasms
1
2004
500
0.040
Why?
Flavin-Adenine Dinucleotide
1
2018
5
0.040
Why?
NAD
1
2018
45
0.040
Why?
Inflammation
1
2022
652
0.030
Why?
Microcirculation
2
2010
63
0.030
Why?
Guidelines as Topic
1
2018
111
0.030
Why?
Microscopy, Fluorescence
1
2018
140
0.030
Why?
Glutathione
1
2019
303
0.030
Why?
Phagocytosis
1
2017
59
0.030
Why?
Glycolysis
1
2017
76
0.030
Why?
Transplantation, Heterologous
2
2008
78
0.030
Why?
Clonal Anergy
2
2006
13
0.030
Why?
Nitroimidazoles
1
2015
16
0.030
Why?
Extracellular Fluid
1
2015
14
0.030
Why?
Microbubbles
1
2015
27
0.030
Why?
Cell Count
1
2015
141
0.030
Why?
Stromal Cells
1
2015
77
0.030
Why?
Pressure
1
2015
102
0.030
Why?
Down-Regulation
2
2006
344
0.030
Why?
Drug Evaluation, Preclinical
1
2015
142
0.030
Why?
Paclitaxel
2
2006
91
0.030
Why?
Cycloaddition Reaction
1
2014
1
0.030
Why?
Radiochemistry
1
2014
2
0.030
Why?
Click Chemistry
1
2014
4
0.030
Why?
Random Allocation
1
2015
284
0.030
Why?
Imaging, Three-Dimensional
1
2015
145
0.030
Why?
Radiotherapy Dosage
1
2015
249
0.030
Why?
Recombinant Proteins
2
2006
489
0.030
Why?
Cell Differentiation
1
2017
681
0.030
Why?
Contrast Media
1
2015
178
0.030
Why?
Molecular Structure
1
2014
320
0.030
Why?
Ultrasonography
1
2015
426
0.030
Why?
Chromatography, High Pressure Liquid
1
2014
333
0.020
Why?
Ribosomal Protein S6 Kinases
1
2012
8
0.020
Why?
Adenylate Kinase
1
2012
10
0.020
Why?
TOR Serine-Threonine Kinases
1
2012
83
0.020
Why?
Rats
2
2008
3162
0.020
Why?
Radiometry
1
2012
125
0.020
Why?
4-Butyrolactone
1
2008
5
0.020
Why?
Butylene Glycols
1
2008
14
0.020
Why?
Phytoestrogens
1
2008
23
0.020
Why?
9,10-Dimethyl-1,2-benzanthracene
1
2008
50
0.020
Why?
Ovariectomy
1
2008
114
0.020
Why?
Receptors, Progesterone
1
2008
68
0.020
Why?
Estrogen Receptor beta
1
2008
54
0.020
Why?
Estrogen Receptor alpha
1
2008
85
0.020
Why?
Carcinogens
1
2008
194
0.020
Why?
Cell Growth Processes
1
2007
24
0.020
Why?
Horseshoe Crabs
1
2006
3
0.020
Why?
Blood Bactericidal Activity
1
2006
4
0.020
Why?
Lipid A
1
2006
4
0.020
Why?
Polymyxin B
1
2006
5
0.020
Why?
Neutralization Tests
1
2006
26
0.020
Why?
Cytidine
1
2006
5
0.020
Why?
Pyrroles
1
2007
73
0.020
Why?
DNA Modification Methylases
1
2006
29
0.020
Why?
Endotoxemia
1
2006
35
0.020
Why?
Acetylation
1
2006
97
0.020
Why?
Methylation
1
2006
127
0.020
Why?
Vimentin
1
2006
31
0.020
Why?
Chick Embryo
1
2006
79
0.020
Why?
Blood Proteins
1
2006
84
0.020
Why?
Gene Silencing
1
2006
122
0.020
Why?
Transfection
1
2007
359
0.020
Why?
Nucleic Acid Hybridization
1
2006
53
0.020
Why?
Cyclohexanes
1
2006
4
0.020
Why?
Histone Deacetylase Inhibitors
1
2006
60
0.020
Why?
Zebrafish
1
2006
61
0.020
Why?
Vascular Cell Adhesion Molecule-1
1
2006
38
0.010
Why?
Histone Deacetylases
1
2006
59
0.010
Why?
Pichia
1
2005
8
0.010
Why?
Gene Transfer Techniques
1
2005
44
0.010
Why?
Cyclophosphamide
1
2006
178
0.010
Why?
Neovascularization, Physiologic
1
2005
86
0.010
Why?
Sequence Homology, Nucleic Acid
1
2004
46
0.010
Why?
Membrane Proteins
1
2006
333
0.010
Why?
Indoles
1
2007
280
0.010
Why?
Treatment Outcome
1
2014
5595
0.010
Why?
Necrosis
1
2004
169
0.010
Why?
Skin
1
2007
419
0.010
Why?
Antibodies
1
2004
147
0.010
Why?
In Situ Nick-End Labeling
1
2003
54
0.010
Why?
Base Sequence
1
2004
620
0.010
Why?
Sequence Homology, Amino Acid
1
2003
135
0.010
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2004
579
0.010
Why?
Epigenesis, Genetic
1
2006
412
0.010
Why?
Mice, Transgenic
1
2004
561
0.010
Why?
RNA, Messenger
1
2004
1133
0.010
Why?
Endothelial Growth Factors
1
2000
11
0.010
Why?
Vascular Endothelial Growth Factors
1
2000
15
0.010
Why?
Fibroblast Growth Factor 2
1
2000
35
0.010
Why?
Lymphokines
1
2000
20
0.010
Why?
Scrotum
1
2000
31
0.010
Why?
Interleukin-1
1
2000
103
0.010
Why?
Models, Biological
1
2002
737
0.010
Why?
Breast Neoplasms
1
2004
1222
0.010
Why?
Dings's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description